Paul J. Menchaca

Paul J. Menchaca

Staff reporter

Paul J. Menchaca is a staff reporter at InvestorsObserver. He's specializing in finance, cryptocurrency, blockchain, and fintech. With a career spanning multiple top-tier publications, including Institutional Investor, FundFire, and InvestmentNews. Based in New York City, Paul brings a deep understanding of financial markets and a knack for breaking down complex topics for a wide audience.

Novo Nordisk product — STOCK UPDATE

Novo Nordisk (NVO) sues Hims & Hers over copycat weight loss pill

February 10, 2026

Circle stock — STOCK UPDATE

Circle (CRCL) partners with Polymarket for on-chain settlement

February 09, 2026

btc — STOCK UPDATE

IREN's stock slumps as its AI pivot can't come fast enough

February 09, 2026

Hims and Hers stock 5 — STOCK UPDATE

Hims & Hers stock slide after FDA warns against copycat drugs

February 09, 2026

quantum computing 5 — STOCK UPDATE

IonQ stock responds to 'false, misleading' short seller report

February 06, 2026

Novo Nordisk product — STOCK UPDATE

Novo Nordisk (NVG) stock might sue Hims & Hers over copycat weight-loss drug

February 06, 2026

IBM stock — STOCK UPDATE

IBM stock expands defense biz with SHIELD contract worth up to $151B

February 06, 2026

Ondas stock — STOCK UPDATE

Ondas (ONDS) boosts defense business with Rotron Aero acquisition

February 05, 2026

Quantum computing — STOCK UPDATE

Short seller claims IonQ lost 'vital' US government contracts

February 05, 2026

crm stock office — STOCK UPDATE

'SaaSpocalypse' shows no signs of ending as software stocks crash

February 05, 2026

1 … 11 12 13 … 80